Die Neigung zu Vitiligo-assoziierter multipler Autoimmunerkrankung 1 kann durch genetische Varianten im NLRP1-Gen, welches ein Apoptose-Regulator kodiert, vermittelt werden.
1. |
Jin Y et. al. (2007) NALP1 in vitiligo-associated multiple autoimmune disease. |
2. |
Bader PI et. al. (1975) Vitiligo and dysgammaglobulinemia. A case report and family study. |
3. |
Majumder PP et. al. (1988) A genetical model for vitiligo. |
4. |
Goudie RB et. al. (1980) Unstable mutations in vitiligo, organ-specific autoimmune diseases, and multiple endocrine adenoma/peptic-ulcer syndrome. |
5. |
Nath SK et. al. (1994) Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. |
6. |
Majumder PP et. al. (1993) Pattern of familial aggregation of vitiligo. |
7. |
Nath SK et. al. (2001) Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. |
8. |
None (1959) Vitiligo. |
9. |
Spritz RA et. al. (2004) Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. |
10. |
Johansson CM et. al. (2004) Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus. |
11. |
Jin Y et. al. (2010) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. |
12. |
Quan C et. al. (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. |
13. |
Jin Y et. al. (2010) Common variants in FOXP1 are associated with generalized vitiligo. |